Maharashtra to Frame New Rules for Illegal Pathology Labs
New Rules Coming for Illegal Pathology Labs in Maharashtra

Nagpur: The Maharashtra Government on Thursday informed the Nagpur bench of the Bombay High Court that the Public Health Department is preparing a new regulatory framework to act against illegal pathology laboratories operating across the state. The proposed rules are expected to be placed before the legislature during the upcoming Assembly session in Mumbai.

Court Hearing on Criminal PIL

Hearing a criminal Public Interest Litigation filed by Yavatmal-based social activist Digambar Pajgade, a division bench comprising Justices Anil Kilor and Raj Wakode directed the government to submit a detailed affidavit by next week outlining the proposed rules and their key provisions.

Allegations of Unqualified Personnel

The petition alleged that thousands of pathology laboratories across Maharashtra are being operated by technicians holding DMLT and CMLT qualifications, despite existing norms requiring such laboratories to function under the supervision of MBBS-qualified doctors or postgraduate medical specialists in pathology, microbiology, or biochemistry.

Wide Pickt banner — collaborative shopping lists app for Telegram, phone mockup with grocery list

According to the plea, the widespread operation of laboratories by inadequately qualified personnel poses a serious threat to public health and compromises the reliability of diagnostic reports relied upon for medical treatment.

Earlier Proceedings

During an earlier hearing, the High Court had sought details regarding action taken by the government against allegedly unauthorised pathology laboratories functioning across the state. In response, the state informed the bench that fresh rules were currently being drafted to address the issue comprehensively.

Strong Observations by the Court

On Thursday, the High Court made strong oral observations regarding the impact of faulty pathology reports on patient care. The judges noted that inaccurate diagnostic findings and delays in the availability of essential medicines in proper quantities often created severe difficulties for patients.

The court advised the Public Health Department to ensure that the proposed regulatory framework incorporates safeguards protecting patients' interests and strengthens accountability within the diagnostic sector.

Pickt after-article banner — collaborative shopping lists app with family illustration